The Food and Drug Administration reports a lack of Zoloft and the generic version of the antidepressant as demand increases and the supply chain for key ingredients is disrupted by the pandemic.
Pfizer, the manufacturer of Zoloft, the FDA said Due to the “increase in demand” for the drug, there is only a limited supply of 100 milligram tablets with 100 pieces. Some other cans from Zoloft are still available.
However, other drug companies also report a lack of sertraline, the generic version of Zoloft, in multiple doses due to a lack of a major ingredient caused by COVID-19 and increased demand.
Especially in China, which has been hit hard by the virus, the supply chains for pharmaceutical components are strained. China produces about two-thirds of the generic ingredients that are used in the United States.
Zoloft is commonly prescribed to treat depression, anxiety, post-traumatic stress disorder, and other mental illnesses.
Experts and advocates say the demand for psychiatric treatments and services has increased during the pandemic as people stay home and practice social distancing. Isolation is a risk factor for poor mental health.